We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

WERFEN

Werfen provides diagnostic instruments for critical care and hemostasis to meet the testing needs of medical professi... read more Featured Products: More products

Download Mobile App





Werfen Introduces GEM Premier 7000 with iQM3 Blood Gas Testing System

By LabMedica International staff writers
Posted on 30 Jul 2024
Print article
Image: The GEM Premier 7000 with Intelligent Quality Management 3 (iQM3) is being unveiled at ADLM 2024 (Photo courtesy of Werfen)
Image: The GEM Premier 7000 with Intelligent Quality Management 3 (iQM3) is being unveiled at ADLM 2024 (Photo courtesy of Werfen)

At the ADLM 2024 Clinical Lab Expo, Werfen (Barcelona, Spain) is featuring its range of hemostasis, acute care, autoimmunity, transfusion and transplant systems, reagents, and digital solutions, and also unveiling its newest innovation in point-of-care (POC) detection.

As the number one source of preanalytical error, hemolysis accounts for up to 70% of all such errors. Despite its prevalence throughout the hospital, hemolysis is not visible in whole blood, and can often go unrecognized. The consequences of in vitro hemolysis can include inappropriate patient management, increased length of stay, and increased costs, among others. At this year’s ADLM Annual Meeting, Werfen is introducing the GEM Premier 7000 with Intelligent Quality Management 3 (iQM3), a breakthrough in blood gas testing that detects hemolysis at the POC.

The GEM Premier 7000 with iQM3 is a portable critical care system for use by health care professionals to rapidly analyze lithium heparinized whole blood samples at the point of health care delivery in a clinical setting and a central laboratory. The instrument provides quantitative measurements of pH, pCO2, pO2, sodium, potassium, chloride, ionized calcium, glucose, lactate, hematocrit, total bilirubin, and CO-Oximetry (tHb, O2Hb, COHb, MetHb, HHb, sO2) parameters from arterial, venous, or capillary lithium heparinized whole blood. These parameters, along with derived parameters, aid in the diagnosis of a patient’s acid/base status, electrolyte and metabolite balance and oxygen delivery capacity.

Werfen is providing a virtual reality laboratory experience to visitors at its booth where they can see 3D customized layouts of HemoCell specialized lab automation workcells for hemostasis labs of all sizes, shapes, and volumes. They can also see how Werfen’s comprehensive autoimmune diagnostics solution can help advance a lab’s capabilities by optimizing efficiency and enhancing clinical decision-making. Additionally, Werfen is presenting an industry workshop titled, Challenges in Pre-Analytical Error Detection: Impact of Hemolysis and Potential Solutions. The workshop will focus on the challenges in pre-analytical error detection, including hemolysis, its prevalence, and its impact on potassium and clinical outcomes. Current strategies and the company’s new technology to detect hemolysis for mitigating risks at the POC will also be discussed.

Related Links:
Werfen

New
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
Silver Member
CEA Assay
Carcinoembryonic Antigen Assay
New
Anti-Annexin V IgG/IgM Assay
Anti-Annexin V IgG/IgM ELISA

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: The new method uses DNA sequencing to measure metabolites (Photo courtesy of 123RF)

New Metabolite Detection Method Using DNA Sequencing Could Transform Diagnostics

Metabolites play a vital role as biomarkers that provide insights into our health, and when their levels go awry, it can lead to diseases such as diabetes and phenylketonuria. Quantifying metabolites remains... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.